Partnership Develops Poultry Bacteriophage Solutions
The collaboration aims to reduce antibiotic reliance in poultry production by targeting bacterial pathogens.
Updated on Oct. 30, 2026 in Life Sciences
Live Poll
Would you feel comfortable eating poultry treated with bacteriophage-based products to combat harmful pathogens?
Phileo by Lesaffre and PhageLab have formed a strategic partnership to develop bacteriophage-based solutions for the poultry industry. This research-stage collaboration aims to create targeted treatments for bacterial pathogens in livestock.
Why it matters
The partnership seeks to address antimicrobial resistance and enhance food safety in poultry production by leveraging virus-based biological tools. It combines industrial-scale feed additive technology with specialized pathogen-targeting research.
PhageLab brings 16 years of research in bacteriophage technology, which uses viruses to selectively eliminate specific bacteria. The partnership integrates this with Phileo’s global feed additive distribution network.
The players
Phileo by Lesaffre
A company specializing in microbial solutions for animal nutrition and health with a broad global market reach.
PhageLab
A research-focused entity founded in 2010 that develops targeted bacteriophage technology for animal health applications.
The details
Bacteriophages — naturally occurring viruses that infect and kill specific bacteria — are used here to target harmful pathogens in poultry. PhageLab employs bacterial diagnostics to identify regional bacterial threats, allowing for the development of customized phage treatments. This data-driven approach aims to reduce the reliance on conventional antimicrobials in the poultry supply chain.
Timeline
PhageLab was founded in 2010.
The strategic partnership was announced on October 30, 2026.
The Tech Race
This partnership marks a shift toward highly targeted pathogen control in the agricultural sector. It follows a growing industry trend of replacing broad-spectrum antibiotic use with precision biological interventions.
The poultry industry in Latin America will gain access to these targeted phage solutions first, with a global rollout planned for later dates. Livestock producers should watch for these products as potential tools to manage regional bacterial challenges without traditional antibiotics.
The takeaway
The move signals a significant effort to scale phage therapy for large-scale agricultural use. Stakeholders should monitor the initial performance results from the Latin American market rollout to gauge the viability of phages against conventional antimicrobials.
Further reading
Learn more about the latest innovations in Life Sciences.
Source note: This article includes information reported by Feedstuffs.
Live Poll
Would you feel comfortable eating poultry treated with bacteriophage-based products to combat harmful pathogens?
